Notice of Meeting, 24860 [E9-12068]
Download as PDF
<![CDATA[
24860
Federal Register / Vol. 74, No. 99 / Tuesday, May 26, 2009 / Notices
Dated: May 18, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E9–12119 Filed 5–22–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following teleconference meetings:
Times and Dates:
12:30 p.m.–12:45 p.m., June 22, 2009 (Open).
12:45 p.m.–7 p.m., June 22, 2009 (Closed).
9 a.m.–9:15 a.m., June 23, 2009 (Open).
9:15 a.m.–5 p.m., June 23, 2009 (Closed).
9 a.m.–9:15 a.m., June 24, 2009 (Open).
9:15 a.m.–5 p.m., June 24, 2009 (Closed).
9 a.m.–9:15 a.m., June 25, 2009 (Open).
9:15 a.m.–5 p.m., June 25, 2009 (Closed).
Place: Teleconference, Toll Free: 877–468–
4185, Participant Pass Code: 3772769.
Status: Portions of the meeting will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct specific
injury research that focuses on prevention
and control.
Matters To Be Discussed: The meetings
will include the review, discussion, and
evaluation of applications submitted in
response to Fiscal Year 2009 Requests for
Applications related to the following
individual research announcement: RFA–
EH–09–001 Climate Change: Environmental
Impact on Human Health (U01).
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Rick Waxweiler, Ph.D., Director, Extramural
Research Program Office, National Center for
Injury Prevention & Control and Executive
Secretary, NCIPC IRG, CDC, 4770 Buford
Highway, N.E., M/S F–62, Atlanta, Georgia
30341, Telephone 770–488-4850.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
Jkt 217001
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: May 15, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9–12068 Filed 5–22–09; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Center for Injury Prevention
and Control Initial Review Group,
(NCIPC IRG)
20:08 May 22, 2009
Dated: May 18, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–12120 Filed 5–22–09; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
VerDate Nov<24>2008
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Accelerating
Development of Methods for the Study
of Complex Patients (R21) applications
are to be reviewed and discussed at this
meeting. These discussions are likely to
reveal personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: Accelerating Development
of Methods for the Study of Complex Patients
(R21).
Date: June 23, 2009 (Open on June 23 from
1 p.m. to 1:15 p.m. and closed for the
remainder of the meeting).
Place: Agency for Healthcare Research and
Quality, John Eisenberg Building, Conference
Center, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Pediatric Functional
Neuroimaging Research Network.
Date: June 26, 2009.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Sathasiva B. Kandasamy,
PhD, Scientific Review Administrator,
Division of Scientific Review, National
Institute of Child Health and Human
Development, 6100 Executive Boulevard,
Room 5B01, Bethesda, MD 20892–9304, (301)
435–6680, skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 74, Number 99 (Tuesday, May 26, 2009)]
[Notices]
[Page 24860]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12068]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for the Accelerating Development of
Methods for the Study of Complex Patients (R21) applications are to be
reviewed and discussed at this meeting. These discussions are likely to
reveal personal information concerning individuals associated with the
applications. This information is exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: Accelerating Development of Methods for the
Study of Complex Patients (R21).
Date: June 23, 2009 (Open on June 23 from 1 p.m. to 1:15 p.m.
and closed for the remainder of the meeting).
Place: Agency for Healthcare Research and Quality, John
Eisenberg Building, Conference Center, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850,
Telephone (301) 427-1554.
Agenda items for this meeting are subject to change as
priorities dictate.
Dated: May 15, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9-12068 Filed 5-22-09; 8:45 am]
BILLING CODE 4160-90-M
